A carregar...
Review of duloxetine in the management of diabetic peripheral neuropathic pain
Duloxetine is a balanced selective serotonin norepinephrine reuptake inhibitor (SNRI) which, in 2004, became the first agent to receive regulatory approval for the treatment of painful diabetic neuropathy in the US. This compound has no other significant receptor or channel activities other than the...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2350145/ https://ncbi.nlm.nih.gov/pubmed/18200804 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|